FMC stock is coming off a very weak run over the past five years, yet the current valuation checks suggest the shares now screen as cheap on several measures. That mix of deep share price losses and a stronger value profile is what many investors are reassessing today.

• Over the past five years, FMC has delivered a total return that declined 85.8%, which has reset expectations and compressed the share price significantly.
• Future cash generation from FMC's crop protection portfolio can support the current share price if margins and execution hold up. However, any further pressure on profitability or balance sheet flexibility would challenge the case that the stock is now attractively priced.
• On Simply Wall St's broader valuation checks, FMC looks cheap across most metrics, with 5 out of 6 signals pointing to undervaluation.

For investors, the debate is whether the sharp multi year share price decline has already more than accounted for FMC's risks, or if the current discount is a sign that the market still sees further fundamental pressure ahead.

Is FMC a Bargain on Sales?

The P/S multiple suits FMC because revenue is still a key reference point even when earnings and free cash flow move around. FMC trades on a P/S of about 0.4x, which is well below the Chemicals industry average of about 1.2x and also below the broader peer group at about 1.4x. That means each dollar of FMC revenue is being valued at a sizeable discount to many other listed chemical companies.

The fair P/S ratio implied by Simply Wall St’s model is about 1.6x, which is much higher than the current 0.4x. This framework considers factors such as FMC’s size, margins, sector, and risk profile, then estimates the multiple that might line up with those characteristics. On that basis the current P/S level suggests the stock is pricing in a lot of caution around FMC’s revenue base.

On the P/S multiple alone, FMC stock appears undervalued compared with both its industry and the modelled fair ratio.

The FMC Narrative: What Would Justify Today's Price?

To connect that valuation puzzle for FMC with the assumptions behind it, Simply Wall St Narratives set out what would need to happen to FMC's revenue, margins and earnings for the stock to be worth materially more or less than today's price, and these sit on the company’s Community page. Rather than relying on a single multiple or model output, each narrative lays out its underlying assumptions so you can compare them with FMC's actual results as they are reported.

One of the top community narratives on FMC: 17% undervalued

"Cost restructuring and market shifts are freeing up capital, which the narrative links to better balance sheet flexibility and earnings power over time…"

Do you think there's more to the story for FMC? Head over to our Community to see what others are saying!

The Bottom Line

FMC appears undervalued on market multiples, with the current P/S ratio implying a meaningful discount to peers and to the modelled fair ratio. The broad valuation checks are strong, which supports the view that the stock price reflects significant caution around its revenue and margin outlook. From here, the key question is whether FMC can stabilise profitability and execution enough for that discount to narrow, or whether the lower multiple is justified because pressure on cash generation and balance sheet flexibility persists.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.